Therapy News and Research

RSS

Short workouts or naps protect memory after sleep deprivation

A short workout or a nap can help protect memory after a sleepless night, a McGill University-led study has found.

24 Aug 2026

Review uncovers how tryptophan metabolism affects female reproductive health

In recent years, issues concerning female reproductive health have become a global challenge that cannot be ignored.

24 Aug 2026

New study makes progress in understanding the mechanisms behind severity of HFpEF

Approximately 3 million people in the United States are living with a condition called heart failure with preserved ejection fraction, or HFpEF.

24 Aug 2026

Combined bio-histological score prevents overtreatment in liver transplant patients

Long‑term outcomes after liver transplantation remain hampered by complications linked to intensive immunosuppression—infections, cardiovascular events, kidney dysfunction, and metabolic disorders affect 10% to 40% of recipients.

24 Aug 2026

Semaglutide’s heart benefits may partly involve reduced inflammation

A prespecified analysis of 17,604 SELECT participants found that higher baseline hsCRP was associated with greater risks of major cardiovascular events and death in people with overweight or obesity and established cardiovascular disease. Semaglutide produced rapid and sustained reductions in hsCRP, with changes emerging before substantial weight loss, although the study could not establish whether reduced inflammation directly mediated its cardiovascular benefits.

24 Aug 2026

Scientists uncover tRNA changes driving Chagas parasite transformation

The Chagas disease parasite (Trypanosoma cruzi) undergoes a major transformation throughout its life cycle in order to infect humans and other mammals.

21 Aug 2026

FDA clears innovative blood test for earlier Alzheimer's diagnosis

The U.S. Food and Drug Administration (FDA) has cleared for marketing an innovative blood test with underlying technology invented at Washington University School of Medicine in St. Louis for the early diagnosis of Alzheimer's disease.

21 Aug 2026

True Grit residential program helps injured youth navigate adult life

Transitioning from high school to adult life is a challenge for anyone, but for young people living with spinal cord injuries, the path forward is less clear.

21 Aug 2026

Neurogenesis stalls in the brains of adults with major depressive disorder, study shows

Most of our brain's 100 billion neurons are created before we're born, but the trickle of neurons created in the adult brain hippocampus could be instrumental in preventing depression, suggest findings from a new study by researchers at Columbia University Vagelos College of Physicians and Surgeons.

21 Aug 2026

Comprehensive review outlines engineering-driven therapeutic pathways for spinal cord injuries

A comprehensive review published in Engineering outlines multi-disciplinary engineering approaches addressing spinal cord injury (SCI), a debilitating central nervous system disorder triggering permanent sensory, motor, and autonomic dysfunction, and imposing heavy burdens on individuals and societies worldwide.

21 Aug 2026

Australian researchers uncover a promising new way to tackle triple-negative breast cancer

Australian researchers have uncovered a promising new way to tackle one of the most aggressive forms of breast cancer, raising hopes for more effective treatments to stop the disease from spreading.

21 Aug 2026

Machine learning model can identify likely non-responders to exercise-based cardiac rehabilitation

Exercise training is a cornerstone of cardiac rehabilitation (CR) for patients with coronary artery disease (CAD), and current guidelines rate it as a top-tier recommendation for reducing the risk of future cardiovascular events.

21 Aug 2026

Younger mismatched donors offer new hope for blood cancer patients

Blood cancer patients who cannot find a closely matched stem cell donor may have more transplant options than previously thought.

21 Aug 2026

Multifunctional nanoplatform addresses three key barriers to effective TNBC immunotherapy

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant subtypes of breast cancer, accounting for 15-20% of all cases.

21 Aug 2026

Scientists identify molecule driving one of the deadliest forms of breast cancer

Australian researchers have uncovered a promising new way to tackle one of the most aggressive forms of breast cancer, raising hopes for more effective treatments to stop the disease from spreading.

21 Aug 2026

Mindfulness-based cognitive therapy does not worsen depression symptoms

Researchers from the University of Wisconsin–Madison's Center for Healthy Minds (CHM), along with UW–Madison Department of Educational Psychology and a multi-university team, have found no evidence that mindfulness-based cognitive therapy (MBCT) increased a risk of symptom worsening, in a meta-analysis published in JAMA Network Open.

21 Aug 2026

Younger lung cancer patients show more targetable gene alterations

Younger adults with non-small cell lung cancer are significantly more likely than older patients to have genetic alterations that can be matched with targeted therapies, according to a large international study led in part by researchers at Sylvester Comprehensive Cancer Center part of the University of Miami Miller School of Medicine.

21 Aug 2026

Scientists uncover safer way to tame cancer cell senescence

Stopping tumor growth is only half the battle. Rather than kill tumor cells, many cancer therapies can only push them into cellular senescence, a state in which cells stop dividing but do not die. These "undead" cells will continue to release signals that reshape the tumor environment.

20 Aug 2026

Potassium-competitive acid blockers match proton pump inhibitors for preventing bleeding after PCI

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) increases the risk of upper gastrointestinal bleeding (UGIB).

20 Aug 2026

Glioma microenvironment emerges as key target for future therapies

The prognosis for glioma patients remains extremely poor despite aggressive multimodal standard therapy: maximal safe resection, radiotherapy, and temozolomide chemotherapy, with median survival rarely exceeding 15 to 18 months.

20 Aug 2026

Previous
1
...
4
5
6
7
8
9
10
...
2932
Next

Therapy News and Research

Short workouts or naps protect memory after sleep deprivation

Review uncovers how tryptophan metabolism affects female reproductive health

New study makes progress in understanding the mechanisms behind severity of HFpEF

Combined bio-histological score prevents overtreatment in liver transplant patients

Semaglutide’s heart benefits may partly involve reduced inflammation

Scientists uncover tRNA changes driving Chagas parasite transformation

FDA clears innovative blood test for earlier Alzheimer's diagnosis

True Grit residential program helps injured youth navigate adult life

Neurogenesis stalls in the brains of adults with major depressive disorder, study shows

Comprehensive review outlines engineering-driven therapeutic pathways for spinal cord injuries

Australian researchers uncover a promising new way to tackle triple-negative breast cancer

Machine learning model can identify likely non-responders to exercise-based cardiac rehabilitation

Younger mismatched donors offer new hope for blood cancer patients

Multifunctional nanoplatform addresses three key barriers to effective TNBC immunotherapy

Scientists identify molecule driving one of the deadliest forms of breast cancer

Mindfulness-based cognitive therapy does not worsen depression symptoms

Younger lung cancer patients show more targetable gene alterations

Scientists uncover safer way to tame cancer cell senescence

Potassium-competitive acid blockers match proton pump inhibitors for preventing bleeding after PCI

Glioma microenvironment emerges as key target for future therapies

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News